Circuit Event and Unfilled Demand
The stock, trading in the EQ series, hit its maximum allowed daily gain of 5.0%, closing at Rs 1,016.15 after touching an intraday high at the same level. The 5% price band capped the rally, effectively freezing trading at the ceiling price. This scenario indicates unfilled demand, where buyers were willing to purchase more shares but were unable to find sellers at higher prices. The total traded volume stood at 43,809 shares, with a turnover of approximately Rs 4.39 crore. The circuit lock means that the rally was halted by regulatory limits rather than a lack of buying interest — what does the full demand picture look like for Venus Remedies Ltd once the circuit unlocks and normal trading resumes?
Delivery and Volume Analysis
Delivery volumes, a key indicator of buying conviction, tell a more nuanced story. On 7 May 2026, the delivery volume was 25,410 shares, which represents a decline of 22.62% compared to the 5-day average delivery volume. This fall suggests that while the stock hit the upper circuit, the buying was not strongly backed by long-term accumulation on the previous day. The total traded volume on the circuit day was mechanically suppressed due to the price lock, which is typical in such scenarios. However, the dip in delivery volume raises the possibility that some of the buying interest may be speculative or driven by short-term momentum rather than sustained demand — is Venus Remedies Ltd's 5% surge backed by improving fundamentals or is this a liquidity-driven micro-cap move? — the delivery data is the most revealing metric on a circuit day.
Momentum just kicked in! This Small Cap from the Auto - Trucks sector entered our list with explosive short-term signals. Catch the wave while it's still building!
- - Fresh momentum detected
- - Explosive short-term signals
- - Early wave positioning
Moving Averages and Trend Context
Venus Remedies Ltd is trading comfortably above all major moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day lines. This alignment confirms a bullish trend that preceded the circuit event. The upper circuit day added 5.0% to the stock price, reinforcing the existing momentum. The narrow intraday range from Rs 972.70 to Rs 1,016.15 suggests that the stock steadily climbed towards the circuit limit without significant retracements. This pattern is typical of a controlled rally where buyers dominate and sellers remain scarce.
Liquidity and Market Capitalisation Context
With a market capitalisation of approximately Rs 1,319 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is modest; based on 2% of the 5-day average traded value, the stock is liquid enough for a trade size of just Rs 0.09 crore. This limited liquidity means that even relatively small orders can move the price significantly, which amplifies the impact of the circuit. For investors, this liquidity risk is crucial — entering or exiting sizeable positions may prove challenging without affecting the price materially. The upper circuit thus reflects not only buying interest but also the thin order book typical of micro-cap stocks — should you be chasing Venus Remedies Ltd given its liquidity constraints?
Intraday Price Action
The stock opened near Rs 972.70 and steadily advanced to the upper circuit price of Rs 1,016.15, marking a 5.0% gain. The intraday range of approximately Rs 43.45 was relatively narrow, reflecting a gradual price appreciation rather than a volatile spike. The circuit lock at the high curtailed further upside, leaving buyers queued up at the ceiling price. This pattern is consistent with a controlled rally where demand outstrips supply at the upper limit, rather than a sharp speculative spike with wide intraday swings.
Fundamental Context
Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space characterised by steady demand and innovation-driven growth. While the micro-cap status suggests a smaller scale compared to industry giants, the company’s recent price action indicates renewed market attention. The sector gained 0.32% on the day, while the Sensex declined by 0.50%, highlighting Venus Remedies Ltd’s relative outperformance. However, the delivery volume decline tempers enthusiasm, signalling that the rally may not yet be fully underpinned by long-term accumulation.
Want to dive deeper on Venus Remedies Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Conclusion: Circuit, Delivery, and Liquidity Signals
The upper circuit hit at Rs 1,016.15 capped a 5.0% gain for Venus Remedies Ltd, signalling strong buying interest that exceeded what the price band could accommodate. However, the decline in delivery volume on the previous day suggests that the move may be driven more by short-term momentum than sustained accumulation. The stock’s position above all major moving averages confirms an existing bullish trend, but the micro-cap liquidity profile introduces a significant risk for investors seeking to transact in meaningful sizes. The circuit locked in gains but also locked out buyers who arrived late, highlighting the thin order book typical of such stocks — after a 5.0% single-day gain at upper circuit, is Venus Remedies Ltd still worth considering or has the move already happened?
Key Data at a Glance
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
